Results

Total Results: 1,939 records

Showing results for "event".

281. Comparative Effectiveness of Adjunctive Devices to Remove Thrombi or Protect Against Distal Embolization in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention of Native Vessels (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/acs-pci-adjunctive-devices_disposition-comments.pdf
     March 01, 2012 - Peer Reviewer #3 Methods What was the reference community and its event rate? … references to specific device names that were used in specific trials, which was commonly done in the event … Peer Reviewer #3 Results If the event rate is quite low, some statisticians might object to the use

282. S58 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s58.pdf
     October 01, 2007 - close examination of the timing of events in relation to treatment initiation, and facilitate use of event … Event history analyses of temporal relationships among health care events are supported, such as incidence … Event history analyses techniques such as Cox regression handle time-to-event data with censoring, and … Incidence and duration of hospitalizations among persons with AIDS: an event history approach.

283. Ventricular Arrhythmias and Cerebrovascular Events in the Elderly Using Conventional and Atypical Antipsychotic Medications | Effective Health Care Program
     effectivehealthcare.ahrq.gov/products/antipsychotic-medicine-cardiovascular-elderly
     March 18, 2009 - Ventricular Arrhythmias and Cerebrovascular Events in the Elderly Using Conventional and Atypical Antipsychotic Medications Timeline January 01, 2005 Topic Initiated March 18, 2009 Research Report Archived Ventricular Arrhythmias and Cerebrovascular Events in…

284. Hepatitis-C-Treatment-Adherence Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c-treatment-adherence_executive.pdf
     September 22, 2011 - interventions versus usual care, (3) patient-level interventions versus usual care, and (4) adverse event … comparing intervention approaches within one intervention category (e.g., system-level or adverse event … Adverse Event Management Interventions Versus Usual Care/Placebo Key Points • There were no studies … of the effects of adverse event management interventions on health outcomes besides QOL. … Adverse Event Management Interventions Versus Usual Care/Placebo The strength of evidence on QOL was

285. Research White Paper: Outcome Measure Harmonization and Data Infrastructure for Patient-Centered Outcomes Research in Depression (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/white-paper-outcome-measure-harmonization-depression.pdf
     November 01, 2020 - Additional procedure codes were added to the Adverse Event value sets. … Potential challenges related to the availability of PHQ-9, adverse event, suicide, and mortality data

286. Research White Paper: Outcome Measure Harmonization and Data Infrastructure for Patient-Centered Outcomes Research in Depression (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/white-paper-outcome-measure-harmonization-depression.pdf
     November 01, 2020 - Additional procedure codes were added to the Adverse Event value sets. … Potential challenges related to the availability of PHQ-9, adverse event, suicide, and mortality data

287. Cer-250-Cannabis-Apps-A-E-Surveillance-Report-2 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-apps-a-e-surveillance-report-2.pdf
     January 01, 2022 - • Other key adverse event outcomes (psychosis, cannabis use disorder, cognitive deficits) and outcomes … ) Insufficient (1) Abbreviations: CBD = cannabidiol; CBDV = cannabidivarin; SAE = serious adverse event … ; SOE = strength of evidence; THC = tetrahydrocannabinol; WAE = withdrawal due to adverse event. … Other key adverse event outcomes (psychosis, cannabis use disorder, cognitive deficits) and outcomes … ; SOE = strength of evidence; THC = tetrahydrocannabinol; WAE = withdrawal due to adverse event

288. Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: Surveillance Report 2 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-apps-a-e-surveillance-report-2-final.pdf
     February 01, 2022 - • Other key adverse event outcomes (psychosis, cannabis use disorder, cognitive deficits) and outcomes … ) Insufficient (1) Abbreviations: CBD = cannabidiol; CBDV = cannabidivarin; SAE = serious adverse event … ; SOE = strength of evidence; THC = tetrahydrocannabinol; WAE = withdrawal due to adverse event. … Other key adverse event outcomes (psychosis, cannabis use disorder, cognitive deficits) and outcomes … ; SOE = strength of evidence; THC = tetrahydrocannabinol; WAE = withdrawal due to adverse event

289. Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: Surveillance Report 2 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-apps-a-e-surveillance-report-2-final_0.pdf
     March 01, 2022 - • Other key adverse event outcomes (psychosis, cannabis use disorder, cognitive deficits) and outcomes … ) Insufficient (1) Abbreviations: CBD = cannabidiol; CBDV = cannabidivarin; SAE = serious adverse event … ; SOE = strength of evidence; THC = tetrahydrocannabinol; WAE = withdrawal due to adverse event. … Other key adverse event outcomes (psychosis, cannabis use disorder, cognitive deficits) and outcomes … ; SOE = strength of evidence; THC = tetrahydrocannabinol; WAE = withdrawal due to adverse event

290. Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: Surveillance Report 2 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-apps-a-e-surveillance-report-2-final_0_0.pdf
     March 01, 2022 - • Other key adverse event outcomes (psychosis, cannabis use disorder, cognitive deficits) and outcomes … ) Insufficient (1) Abbreviations: CBD = cannabidiol; CBDV = cannabidivarin; SAE = serious adverse event … ; SOE = strength of evidence; THC = tetrahydrocannabinol; WAE = withdrawal due to adverse event. … Other key adverse event outcomes (psychosis, cannabis use disorder, cognitive deficits) and outcomes … ; SOE = strength of evidence; THC = tetrahydrocannabinol; WAE = withdrawal due to adverse event

291. Urinary-Incontinence-Treatment Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/urinary-incontinence-treatment_research-protocol.pdf
     September 30, 2010 - differences in rates of outcomes events in the active and control groups: 92,99 1 / (control group event … rate - treatment group event rate). … number of avoided or excess events (respectively) per 1000 population is the difference between the two event … rates multiplied by 1000: (control group event rate - treatment group event rate)*1000 We will … Summary of Protocol Amendments In the event of protocol amendments, the date of each amendment will

292. Disposition of Comments Report for Recurrent Nephrolithiasis in Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-stone-prevention_disposition-comments.pdf
     July 26, 2012 - That said, we would caution this reviewer regarding comparing the event rate in the low calcium group … in the Borghi 2002 trial with the event rate in the control group in different studies. … We looked for any language that indicated that their most recent stone event was past. … The authors propose that the primary endpoint should be symptomatic stone event. … some “symptomatic” episodes, if not documented radiographically, may not actually reflect a stone event

293. Bladder-Cancer-Non-Muscle-Invasive Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/bladder-cancer-non-muscle-invasive_executive.pdf
     October 01, 2015 - BCG Versus MMC: • BCG was associated with increased risk of any local adverse event (2 trials; RR, … • BCG was associated with increased risk of any systemic adverse event (2 trials; RR, 2.01; 95% CI … moderate for cystitis and hematuria) BCG was associated with increased risk of any local adverse event … MMC: Systemic adverse events Low BCG was associated with increased risk of any systemic adverse event

294. Radiation Therapy for Bone Metastases | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/get-involved/nominated-topics/radiation-therapy-bone-metastases
     July 17, 2020 - dependence on pain medication, need for further pain intervention, quality of life, rate of musculoskeletal event

295. CER 215 Adverse Effects of Pharmacologic Treatments of Major Depression in Older Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-215-depression-older-adults-comments.pdf
     March 28, 2019 - Severity information, particularly for the outcomes of “any adverse event” and “withdrawal due to … “The risk of any adverse event…”was not different” instead of “were no different”. … Results Page 36, Figure 3: Would be helpful to add the results of the meta‐analysis of any adverse event … the reason that individuals were being treated and seems difficult to conceptualize as an adverse event … Reviewer #1, American Psychiatric Association Results p. 17, 3rd paragraph “events” should be “event

296. CER 215 Adverse Effects of Pharmacologic Treatments of Major Depression in Older Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-215-depression-older-adults-comments.pdf
     March 28, 2019 - Severity information, particularly for the outcomes of “any adverse event” and “withdrawal due to … “The risk of any adverse event…”was not different” instead of “were no different”. … Results Page 36, Figure 3: Would be helpful to add the results of the meta‐analysis of any adverse event … the reason that individuals were being treated and seems difficult to conceptualize as an adverse event … Reviewer #1, American Psychiatric Association Results p. 17, 3rd paragraph “events” should be “event

297. Making Healthcare Safer IV: Summary of Findings, 2023-2024 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-1-year-final-report-updated-title_0.pdf
     May 01, 2024 - Making Healthcare Safer IV: Summary of Findings, 2023-2024 Making Healthcare Safer IV Making Healthcare Safer IV: Summary of Findings on Patient Safety Practices and Ratings by a Technical Expert Panel, 2023-2024 Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Se…

298. Cer-250-Cannabis-Apps-A-E-Surveillance-Report-2 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/cer-250-cannabis-apps-a-e-surveillance-report-2.pdf
     January 01, 2022 - • Other key adverse event outcomes (psychosis, cannabis use disorder, cognitive deficits) and outcomes … ) Insufficient (1) Abbreviations: CBD = cannabidiol; CBDV = cannabidivarin; SAE = serious adverse event … ; SOE = strength of evidence; THC = tetrahydrocannabinol; WAE = withdrawal due to adverse event. … Other key adverse event outcomes (psychosis, cannabis use disorder, cognitive deficits) and outcomes … ; SOE = strength of evidence; THC = tetrahydrocannabinol; WAE = withdrawal due to adverse event

299. Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: Surveillance Report 2 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/cer-250-cannabis-apps-a-e-surveillance-report-2-final.pdf
     March 01, 2022 - • Other key adverse event outcomes (psychosis, cannabis use disorder, cognitive deficits) and outcomes … ) Insufficient (1) Abbreviations: CBD = cannabidiol; CBDV = cannabidivarin; SAE = serious adverse event … ; SOE = strength of evidence; THC = tetrahydrocannabinol; WAE = withdrawal due to adverse event. … Other key adverse event outcomes (psychosis, cannabis use disorder, cognitive deficits) and outcomes … ; SOE = strength of evidence; THC = tetrahydrocannabinol; WAE = withdrawal due to adverse event

300. Treatment Strategies for Patients With Peripheral Artery Disease | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/peripheral-artery-disease-treatment/research
     May 29, 2013 - Current Page Topic Timeline Jan. 20, 2011 Topic Suggestion Jan. 31, 2012 Research Protocol May. 29, 2013 Systematic Review Sep. 12, 2013 Disposition of Comments Report Treatment Strategies for Patients With Peripheral Artery Disease Systematic Review Archived May 29, 2013 Web Version [NLM Site] Download Main Docum…